Coronavirus patients hospitalized in intensive care units in the United Kingdom are set to receive a new treatment.
Clinical trials found drugs typically used to treat rheumatoid arthritis could help save lives and reduce hospital time by 10 days.
Results from the government-funded trial show they reduced the relative risk of death by 24% when administered within 24 hours of entering intensive care.
The trial has yet to be peer reviewed.
© 2023 - 910 Media Group
